19-51345270-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001985.3(ETFB):c.709G>A(p.Val237Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000222 in 1,614,230 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001985.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETFB | NM_001985.3 | c.709G>A | p.Val237Ile | missense_variant | 6/6 | ENST00000309244.9 | NP_001976.1 | |
ETFB | NM_001014763.1 | c.982G>A | p.Val328Ile | missense_variant | 5/5 | NP_001014763.1 | ||
ETFB | XM_024451418.2 | c.598G>A | p.Val200Ile | missense_variant | 6/6 | XP_024307186.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETFB | ENST00000309244.9 | c.709G>A | p.Val237Ile | missense_variant | 6/6 | 1 | NM_001985.3 | ENSP00000311930 | P1 | |
ETFB | ENST00000354232.8 | c.982G>A | p.Val328Ile | missense_variant | 5/5 | 1 | ENSP00000346173 | |||
ENST00000600974.1 | n.78+24C>T | intron_variant, non_coding_transcript_variant | 3 | |||||||
ETFB | ENST00000596253.1 | downstream_gene_variant | 3 | ENSP00000469628 |
Frequencies
GnomAD3 genomes AF: 0.000256 AC: 39AN: 152226Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000199 AC: 50AN: 251458Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135906
GnomAD4 exome AF: 0.000219 AC: 320AN: 1461886Hom.: 0 Cov.: 32 AF XY: 0.000235 AC XY: 171AN XY: 727246
GnomAD4 genome AF: 0.000256 AC: 39AN: 152344Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74506
ClinVar
Submissions by phenotype
not provided Uncertain:2Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | May 08, 2018 | - - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 19, 2021 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2016 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 30, 2024 | The c.709G>A (p.V237I) alteration is located in exon 6 (coding exon 6) of the ETFB gene. This alteration results from a G to A substitution at nucleotide position 709, causing the valine (V) at amino acid position 237 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Multiple acyl-CoA dehydrogenase deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 25, 2022 | This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 237 of the ETFB protein (p.Val237Ile). This variant is present in population databases (rs149129214, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with ETFB-related conditions. ClinVar contains an entry for this variant (Variation ID: 203700). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ETFB protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at